TolDec clinical trials

Dendritic cells therapy combined with immunomodulatory treatment in multiple sclerosis

This study is looking at a new treatment called TolDec for multiple sclerosis (MS). It combines a special cell therapy with other medicines to see if it can reduce new MS lesions and is safe for patients.